Economic issues and antibiotic resistance in the community

Annals of Pharmacotherapy

Volumn 36, Issue 1, 2002, Pages 148-154

  Reed, Shelby D ^a   Laxminarayan, Ramanan ^b   Black, Doug J ^a   Sullivan, Sean D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b RESOURCES FOR THE FUTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; COMMUNITY CARE; DRUG COST; DRUG MARKETING; DRUG MISUSE; HEALTH CARE POLICY; HUMAN; MEDLINE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE; HUMANS; SOCIOECONOMIC FACTORS;

EID: 0036142076     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A121     Document Type: Review

References (55)

1. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
2. Interaction between antimicrobial consumption and selection of resistant bacterial strains
3. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods
4. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis
5. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians
6. Patient knowledge of upper respiratory tract infections: Implications for antibiotic expectations and unnecessary utilization
7. Economics of antibiotic resistance: A theory of optimal use
8. Current attitudes regarding use of antimicrobial agents: Results from physicians’ and parents’ focus group discussions
9. The effect of cost sharing on the use of antibiotics in ambulatory care: Results from a population-based randomized controlled trial
10. Measuring the indirect and direct costs of acute otitis media
11. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio
12. Antibiotic utilization: Is there an effect on antimicrobial resistance?
13. Appropriate use of antibiotics for URIs in children: Part II. Cough, pharyngitis and the common cold
14. Appropriate use of antibiotics for URIs in children: Part I. Otitis media and acute sinusitis
15. Antibiotic prescribing for Canadian preschool children: Evidence of overprescribing for viral respiratory infections
16. National trends in the use of antibiotics by primary care physicians for adult patients with cough
17. Overuse of antibiotics for upper respiratory tract infections in emergency departments: Results from a national study
18. Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: Questionnaire study
19. Prescribing and referral in general practice: A study of patients’ expectations and doctors’ actions
20. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior
21. Method of physician remuneration and rates of antibiotic prescription
22. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met?
23. Are patients more satisfied when they receive a prescription? The effect of patient expectations in general practice
24. Evaluation and treatment of respiratory infections: Does managed care make a difference?
25. Cultural and economic factors that (mis)shape antibiotic use: The nonpharmacologic basis of therapeutics
26. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers
27. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries
28. Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis
29. The economic impact of Staphylococcus aureus in New York City hospitals
30. Nosocomial outbreak of ampicillin resistant Enterococcus faecium: Risk factors for infection and fatal outcome
31. Bug/drug resistance: Sometimes more is less
32. Superbugs: Should antimicrobial resistance be included as a cost in economic evaluation?
33. Doubling the estimated value of life: Results using new occupational fatality data
34. Toward multinational antimicrobial resistance surveillance systems in Europe
35. The population genetics of antibiotic resistance
36. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
37. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
38. Impact of therapeutic guidelines on antibiotic use by residents in primary care clinics
39. Physician management of hypercholesterolemia: A randomized trial of continuing medical education
40. Efforts to improve compliance with the National Cholesterol Education Program guidelines: Results of a randomized controlled trial
41. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academic "detailing
42. Persistence of improvement in antibiotic prescribing in office practice
43. Influencing antibiotic prescribing in general practice: A trial of prescriber feedback and management guidelines
44. Confidential prescriber feedback and education to improve antibiotic use in primary care: A controlled trial
45. Decreasing antibiotic use in ambulatory practice: Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults
46. An evaluation of statewide strategies to reduce antibiotic overuse
47. Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients
48. Antibiotic cycling and marketing into the 21st century: A perspective from the pharmaceutical industry
49. Drug firms restock antibacterial arsenal
50. Antimicrobial resistance - New directions
51. Global surveillance of antibiotic resistance